Reverse phase protein array (RPPA) technology introduced a miniaturized "antigen-down"
or "dot-blot" immunoassay suitable for quantifying the relative, semi-quantitative or …

Genotyping graft livers by short tandem repeats after human living-donor liver transplantation
(n = 20) revealed the presence of recipient or chimeric genotype cases in hepatocytes (6 of …

Pancreatic cancer is the fourth leading cause of cancer-related deaths in Japan. To identify
risk loci, we perform a meta-analysis of three genome-wide association studies comprising …

The ultimate goal of cancer biomarker discovery is to use individual patient-derived
biochemical information to improve patients' outcomes. A recent increase in the spectrum of …

Background Circulating tumor DNA (ctDNA) carries information on tumor burden. However,
the mutation spectrum is different among tumors. This study was designed to examine the …

Background Paradoxically, Helicobacter pylori–positive (HP + ) advanced gastric cancer
patients have a better prognosis than those who are HP–negative (HP - ). Immunologic and …

Primary liver cancer is a heterogeneous disease in terms of its etiology, histology, and therapeutic
response. Concurrent proteomic and genomic characterization of a large set of clinical …

… Nishizuka received grant/research support form Array Jet, Taiho Pharmaceuticals, …
Takeshi Iwaya and Satoshi S. Nishizuka hold a patent that might benefit from this publication (…

We investigated whether early circulating tumor DNA (ctDNA) changes, measured using
digital PCR (dPCR), can predict later chemotherapy responses in esophageal squamous cell …

… Author links open overlay panel Chie Ito MD a b , Satoshi S. Nishizuka MD, PhD a b c 1 ,
Kazuyuki Ishida MD, PhD d , Noriyuki Uesugi MD, PhD d , Tamotsu Sugai MD, PhD d , Gen …